- Filed
- Mar 25, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 18, 2025 | 215.25M sh |
| Long Term Debt | FY 2024 · Dec 31, 2024 | $488.93K |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 129.42M sh |
| Capex | FY 2024 · Dec 31, 2023 | $88K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$519.79K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $1.07M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $2.07M |
| Current Assets | FY 2024 · Dec 31, 2023 | $549.22K |
| Total Assets | FY 2024 · Dec 31, 2023 | $3.23M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | $0.00 |
| Eps Basic | FY 2024 · Dec 31, 2023 | $0.00 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $459.88K |
| Net Income | FY 2024 · Dec 31, 2023 | −$291.67K |
| Operating Income | FY 2024 · Dec 31, 2023 | −$452.6K |
| Gross Profit restated | FY 2024 · Dec 31, 2023 | $22.41K |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2023 | $81.66K |
| Revenue | FY 2024 · Dec 31, 2023 | $104.07K |